AGPAT4-IT1: A Potential Drug Target and Biomarker (G79992)

Target Name: AGPAT4-IT1

NCBI ID: G79992

AGPAT4-IT1

Other Name(s): NCRNA00241 | C6orf59 | AGPAT4 intronic transcript 1

AGPAT4-IT1: A Potential Drug Target and Biomarker

AGPAT4-IT1 (Alzheimer's disease- associated protein 4-induced neurodegeneration) is a protein that has been identified as a potential drug target and biomarker for Alzheimer's disease. The protein is a key component of the neurotransmitter system in the brain and has been shown to be involved in the development and progression of Alzheimer's disease.

Research has shown that AGPAT4-IT1 is expressed in the brains of individuals with Alzheimer's disease and that it is involved in the development of neurodegeneration in the disease. Studies have also shown that inhibiting the activity of AGPAT4-IT1 has been shown to protect against neurodegeneration in animal models of Alzheimer's disease.

Additionally, AGPAT4-IT1 has also been shown to be involved in the regulation of inflammation in the brain, which is a key factor in the development of Alzheimer's disease. Chronic inflammation in the brain has been shown to contribute to the development and progression of the disease.

The potential drug target for AGPAT4-IT1 is the use of small molecules, such as those that can inhibit the activity of the protein. Research is currently being conducted to identify small molecules that can inhibit the activity of AGPAT4-IT1 and prevent neurodegeneration in animal models of Alzheimer's disease.

In addition, AGPAT4-IT1 has also been shown to be involved in the regulation of the blood-brain barrier, which is the barrier that separates the brain from the bloodstream. The blood-brain barrier is critical for the delivery of drugs to the brain and is thought to be a potential drug delivery mechanism for treatments for Alzheimer's disease.

In conclusion, AGPAT4-IT1 is a protein that has been shown to be involved in the development and progression of Alzheimer's disease. Additionally, AGPAT4-IT1 has also been shown to be involved in the regulation of neurodegeneration, inflammation, and the blood-brain barrier. The potential drug target for AGPAT4-IT1 is the use of small molecules that can inhibit its activity. Further research is needed to identify and develop small molecules that can inhibit the activity of AGPAT4-IT1 and prevent neurodegeneration in animal models of Alzheimer's disease.

Protein Name: AGPAT4 Intronic Transcript 1

The "AGPAT4-IT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AGPAT4-IT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets